Insights

Expanding Facilities Novartis is investing heavily in infrastructure, including a $23 billion US expansion and a new research facility in San Diego. This indicates a significant growth phase, creating opportunities for partnerships, supply chain solutions, and facility services.

Strategic Collaborations Recent partnerships with Teva Canada and TB Alliance highlight Novartis’s focus on expanding treatment options and tackling complex diseases like multiple sclerosis and leprosy. These collaborations open avenues for co-developing technologies, research tools, and clinical trial services.

Innovative Research Pipeline With over 50 ongoing Phase III trials and a focus on developing Alzheimer’s drugs, Novartis is at the forefront of cutting-edge medicine development. This creates opportunities for suppliers of innovative research technologies, clinical trial management, and specialized healthcare solutions.

Market Engagement Strategies Active participation in high-profile marketing campaigns such as the Super Bowl for prostate cancer awareness presents an opening for healthcare communicators, patient engagement platforms, and promotional agencies looking to collaborate with pharmaceutical brands.

Technological Adoption Novartis employs a range of advanced digital tools and software including SCADA, Calabrio, and digital product delivery systems, indicating a readiness to adopt new technologies, which presents opportunities for tech vendors specializing in healthcare IT, analytics, and AI-driven solutions.

Novartis, Australia & New Zealand Tech Stack

Novartis, Australia & New Zealand uses 8 technology products and services including QuickBooks, Adobe Illustrator, SCADA, and more. Explore Novartis, Australia & New Zealand's tech stack below.

  • QuickBooks
    Accounting And Finance
  • Adobe Illustrator
    Cad & Graphics
  • SCADA
    Control Systems
  • Calabrio
    Customer Experience Management
  • Argo Project
    Data Management Platforms
  • Digital Product Delivery
    E-commerce Platforms
  • Android
    Programming Languages
  • GraphPad Prism
    Visualisation Software

Media & News

Novartis, Australia & New Zealand's Email Address Formats

Novartis, Australia & New Zealand uses at least 1 format(s):
Novartis, Australia & New Zealand Email FormatsExamplePercentage
First.Last@novartis.comJohn.Doe@novartis.com
89%
F.Last@novartis.comJ.Doe@novartis.com
5%
FiLast@novartis.comJoDoe@novartis.com
3%
FLast@novartis.comJDoe@novartis.com
3%

Frequently Asked Questions

Where is Novartis, Australia & New Zealand's headquarters located?

Minus sign iconPlus sign icon
Novartis, Australia & New Zealand's main headquarters is located at 54 Waterloo Road Macquarie Park, New South Wales 2113 Australia. The company has employees across 6 continents, including OceaniaAsiaNorth America.

What is Novartis, Australia & New Zealand's phone number?

Minus sign iconPlus sign icon
You can contact Novartis, Australia & New Zealand's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Novartis, Australia & New Zealand's official website and social media links?

Minus sign iconPlus sign icon
Novartis, Australia & New Zealand's official website is novartis.com and has social profiles on LinkedIn.

What is Novartis, Australia & New Zealand's NAICS code?

Minus sign iconPlus sign icon
Novartis, Australia & New Zealand's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Novartis, Australia & New Zealand have currently?

Minus sign iconPlus sign icon
As of March 2026, Novartis, Australia & New Zealand has approximately 246 employees across 6 continents, including OceaniaAsiaNorth America. Key team members include Chief Scientific Officer: D. V. V.Head Of Customer Experience And Omnichannel: A. L.Head Of New Channels: A. C.. Explore Novartis, Australia & New Zealand's employee directory with LeadIQ.

What industry does Novartis, Australia & New Zealand belong to?

Minus sign iconPlus sign icon
Novartis, Australia & New Zealand operates in the Pharmaceutical Manufacturing industry.

What technology does Novartis, Australia & New Zealand use?

Minus sign iconPlus sign icon
Novartis, Australia & New Zealand's tech stack includes QuickBooksAdobe IllustratorSCADACalabrioArgo ProjectDigital Product DeliveryAndroidGraphPad Prism.

What is Novartis, Australia & New Zealand's email format?

Minus sign iconPlus sign icon
Novartis, Australia & New Zealand's email format typically follows the pattern of First.Last@novartis.com. Find more Novartis, Australia & New Zealand email formats with LeadIQ.

How much funding has Novartis, Australia & New Zealand raised to date?

Minus sign iconPlus sign icon
As of March 2026, Novartis, Australia & New Zealand has raised $2.4B in funding. The last funding round occurred on Sep 16, 2020 for $2.1B.

Novartis, Australia & New Zealand

Pharmaceutical ManufacturingNew South Wales, Australia201-500 Employees

Novartis is improving the lives of more than 2.5 million patients across Australia and New Zealand through our medicines. By partnering with the healthcare system we are working for patients to address their needs, and we are committed to accelerating patient access to life saving treatments and associated healthcare.
 
We are reimagining medicine by using innovative science and technology to address challenging healthcare issues and our rich research pipeline has 50+ ongoing Phase III programs. We are transforming how clinical trials are run to increase patients’ access to our industry-leading clinical trials footprint in Australia.
 
We continue to work on improving our environment for diversity, equity and inclusion and being a family friendly employer. Every day our inspired, curious, unbossed, and integrity-driven culture unites our people and encourages leadership at every level.  

See our community guidelines here: https://bit.ly/2meXCdH

Novartis is aware of employment scams which make false use of our company name or leader’s names to defraud job seekers. Novartis does not make job offers without interview and never asks candidates for money. All our current job openings are displayed here and on our novartis.com.au website.

If you have encountered a job posting or been approached with a job offer that you suspect may be fraudulent, we strongly recommend you do not respond, send money or personal information.

Section iconCompany Overview

Headquarters
54 Waterloo Road Macquarie Park, New South Wales 2113 Australia
Phone number
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
201-500

Section iconFunding & Financials

  • $2.4B

    Novartis, Australia & New Zealand has raised a total of $2.4B of funding over 3 rounds. Their latest funding round was raised on Sep 16, 2020 in the amount of $2.1B.

  • $50M$100M

    Novartis, Australia & New Zealand's revenue is estimated to be in the range of $50M$100M

Section iconFunding & Financials

  • $2.4B

    Novartis, Australia & New Zealand has raised a total of $2.4B of funding over 3 rounds. Their latest funding round was raised on Sep 16, 2020 in the amount of $2.1B.

  • $50M$100M

    Novartis, Australia & New Zealand's revenue is estimated to be in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.